(Reuters) – Philip Morris International published quarterly results superior to expectations on Thursday, thanks to the high demand for its alternative products to conventional cigarettes, such as Nicotine Zyn sachets.
The action of the world’s leading cigaret tree climbs almost 8% in a forefoot.
Philip Morris declared an adjusted profit of 1.55 dollars per share under the closed quarter on December 31, while analysts tabblated on $ 1.50 per share, according to data compiled by LSEG.
Tobacco substitutes, such as Zyn sachets, have experienced high demand in recent years on the part of smokers which, concerned by the consequences of health tobagism, are looking for other means of consuming nicotine.
The American Medicines Agency (FDA) granted Philip Morris last January a marris authorization to these sachets of tobacco-free nicotine in the United States, arguing that this product presented a reduced risk of serious health problems in reason for significantly lower quantities of harmful components.
Smoke -free uninhaleted products volumes increased by 25% during the fourth quarter compared to the previous year, thanks to the growth in demand for nicotine sachets on the American market.
The Cigarettier also anticipated an annual profit adjusted by share between 7.04 and $ 7.17, which is also greater than analysts, which were tabbling on 7.03 dollars.
(Written by Aamir Sohail in Bangalore; Diana Mandia, edited by Blandine Hénault)
Copyright © 2025 Thomson Reuters
I have over 8 years of experience working in the news industry. I have worked as a reporter, editor, and now managing editor at 247 News Agency. I am responsible for the day-to-day operations of the news website and overseeing all of the content that is published. I also write a column for the website, covering mostly market news.
